Skip to main content

Peer Review reports

From: Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports

Original Submission
16 Apr 2021 Submitted Original manuscript
21 Apr 2021 Author responded Author comments - Alex Hodkinson
Resubmission - Version 2
21 Apr 2021 Submitted Manuscript version 2
27 Apr 2021 Reviewed Reviewer Report - Georgios Kotzalidis
20 May 2021 Reviewed Reviewer Report - Henk Temmingh
29 May 2021 Reviewed Reviewer Report
21 Jun 2021 Author responded Author comments - Alex Hodkinson
Resubmission - Version 3
21 Jun 2021 Submitted Manuscript version 3
22 Jun 2021 Reviewed Reviewer Report
24 Jun 2021 Reviewed Reviewer Report - Georgios Kotzalidis
9 Jul 2021 Reviewed Reviewer Report - Henk Temmingh
12 Jul 2021 Author responded Author comments - Alex Hodkinson
Resubmission - Version 4
12 Jul 2021 Submitted Manuscript version 4
Publishing
13 Jul 2021 Editorially accepted
25 Aug 2021 Article published 10.1186/s12916-021-02062-w

You can find further information about peer review here.

Back to article page